Knockout™ Serum Replacement (Knockout™ SR) is for serum-free, feeder-based culture of embryonic stem cells (ESCs) and induced Pluripotent stem cellsRead more
Have Questions?
Change view
Catalog Number
Quantity
10828010
100 mL
10828028
500 mL
2 Options
Catalog number 10828010
Price (USD)
126.00
Each
Add to cart
Quantity:
100 mL
Price (USD)
126.00
Each
Add to cart
Knockout™ Serum Replacement (Knockout™ SR) is for serum-free, feeder-based culture of embryonic stem cells (ESCs) and induced Pluripotent stem cells (iPSCs) from multiple species. This defined, serum-free formulation directly replaces FBS in existing protocols.
Many of the drawbacks of using FBS in stem cell culture, (differentiation of cells and heat-inactivation) can be alleviated with the use of KnockOut™ Serum Replacement. ES and iPS cells grown in KnockOut™ SR-supplemented media are substantially less differentiated than those grown in FBS-supplemented media, and germline transmission should not be compromised. With over 2000 peer-reviewed publications covering applications such as stem cell culture, differentiation, iPSC generation, ESC derivation, and transgenic modeling, KnockOut™ Serum Replacement is widely cited for stem cell culture.
Specifications
ClassificationSerum-Free
Culture TypeMammalian Cell Culture
Cell TypeStem Cells (Embryonic)
SpeciesSerum-Free
FormFrozen
Serum LevelSerum-Free
Product TypeSerum Replacement
Quantity100 mL
Tested ForGrowth Performance Assay
Manufacturing QualitycGMP for medical devices, 21 CFR Part 820 and ISO 13485
For Use With (Application)Clinical Research, Translational Research
Green FeaturesSustainable packaging
Purity or Quality GradeES Cell-Qualified
Product LineKnockOut™
pH6 to 8
Shelf Life18 Months
Shipping ConditionDry Ice
Unit SizeEach
Contents & Storage
Store in freezer (-5 to -20°C) and protect from light.
Frequently asked questions (FAQs)
Can KnockOut SR be used to culture mouse ESCs in feeder-free conditions?
Yes, mouse embryonic stem cells can be cultured using KnockOut SR under feeder-free conditions. Typically, cells are plated at a higher seeding density, in the presence of LIF, on a 0.1% gelatin layer in place of feeder cells.
How do I characterize human embryonic stem ( ES) cells?
Human ES cells are generally characterized by their typical morphology (they grow as tightly packed clusters of small cells with high ratio of nucleus to cytoplasm); surface marker expression; RT-PCR detection of stem cell-specific gene expression (such as Oct3/4, Sox2, and Nanog); alkaline phosphatase staining, and telomerase activity assay. The most commonly used ES specific surface markers include stage-specific embryonic antigens SSEA-3 and SSEA-4 for human ES cells. Other ES-specific surface antigens also include TRA-1-60 and TRA-1-81. (Science 282:1145 (1998).
How are human embryonic stem (ES) cells derived?
Human ES cells are derived from human blastocyst inner cell masses, isolated by immunosurgery with rabbit antiserum to BeWO cells (a human trophoblast cell line) (Science 282:1145 (1998)).
What are ES cells?
Embryonic stem (ES) cells are derived from the early mammalian embryo and are capable of unlimited, undifferentiated proliferation in vitro while maintaining their potential to differentiate into a wide of range of adult tissues including germ cells. The pluripotency of the ES cells is normally demonstrated in vitro by inducing ES cells to differentiate into embryoid bodies and checking lineage-specific markers for differentiated cells in three body layers (endo, meso, and ectoderm), or injecting them into immunodeficient mice and determining the cell types produced in the teratomas.